Quote | Super Quote
13611 MB-SBPH@EC2510A (CALL)
RT Nominal unchange 0.000 (0.000%)

26/01/2024 15:33

{I-bank focus}HSBC lowers Sino Biopharm (01177) to HKD4.6

[ET Net News Agency, 26 January 2024] HSBC Global Research lowered its target price for
Sino Biopharm (01177) to HKD4.6 from HKD5 and maintained its "buy" rating.
The research house said it estimates innovative drugs sales will reach nearly RMB10bn in
2024 from around RMB7.8bn in 2023, implying over 25% growth y-o-y. (RC)

Remark: Real time quote last updated: 01/11/2024 07:35
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.